AMGEN Inc.

NASDAQ:AMGN  
227.57
-1.33 (-0.58%)
4:00:02 PM EDT: $227.72 +0.15 (+0.07%)
Products

U.S. FDA Approves Darzalex Faspro In Combination With Carfilzomib And Dexamethasone

Published: 12/01/2021 18:41 GMT
AMGEN Inc. (AMGN) - :u.s. FDA Approves Darzalex Faspro® (daratumumab and Hyaluronidase-fihj) in Combination With Carfilzomib and Dexamethasone for Patients With Multiple Myeloma After First Or Subsequent Relapse.
Janssen - Approval of Darzalex Faspro Follows Regulatory Submission to FDA in February 2021.